ZYMEZymeworks Inc.
$25.80+59% 1Y
$25.80
$16.1652 weeks$31.05
ZYME in its own filings
Nothing in ZYME's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
106
Events found in the filings · across 331 filings · the record starts in 2022
- Hard flags
- none
Hard flags
- Most recent filing
- Sep 23, 2026
Most recent filing · Form 8-K
- Record starts
- Aug 8, 2022
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- Security removed from listing or deregisteredhistorical · usually a matured note or preferred class, not the common shares
- 2022-12-15
- SEC comment-letter activity3 occurrences
- 2022-08-30
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 23, 2026Contingent Value Rights Agreement On September 22, 2026, in connection with the consummation of the Merger and in accordance with the Merger Agreement, Zymeworks, Computershare Inc. (“Computershare”) and Computershare Trust Company, N.A., acting jointly with Computershare, as rights agent (the “Rights Agent”), entered …Material agreement entered · Form 8-K
- Aug 25, 2026REGULATION FD DISCLOSURES Zymeworks BC Inc. (“Zymeworks”), a subsidiary of the Company, is a party to an Amended and Restated License and Collaboration Agreement (as amended, the “License and Collaboration Agreement”) with Jazz Pharmaceuticals Ireland Limited, a subsidiary of Jazz Pharmaceuticals plc, collectively …Regulation FD disclosure · Form 8-K
- Aug 6, 2026Zymeworks Provides Corporate Update and.Earnings release · press release
- Jun 29, 2026Agreement and Plan of Merger On June 28, 2026, Zymeworks Inc., a Delaware corporation (“Zymeworks” or “Parent”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Zymeworks Merger Sub 1, an exempted company with limited liability incorporated under the Laws of the Cayman Islands and a wholly …Material agreement entered · Form 8-K
- May 14, 2026On May 14, 2026, Zymeworks Inc. (the “Company”) issued a press release announcing that its Board of Directors (the “Board”) had authorized a share repurchase program (the “2026 Share Repurchase Program”) under which the Company may repurchase up to $125.0 million of the Company’s common stock, par value $0.00001 per …Regulation FD disclosure · Form 8-K
- May 7, 2026Zymeworks Provides Corporate Update and.Earnings release · press release
- Apr 1, 2026Appointment of Executive Vice President, Chief Financial Officer On March 31, 2026, Zymeworks Inc. (the “Company”) appointed Ms. Kristin Stafford, age 44, as Executive Vice President, Chief Financial Officer of the Company, effective upon her commencement of employment with the Company on April 1, 2026 (the “Start …Director or officer change · Form 8-K
- Mar 2, 2026Zymeworks Provides Corporate Update and.Earnings release · press release
- Mar 2, 2026On March 2, 2026, Zymeworks BC Inc. (“Zymeworks BC”), a subsidiary of Zymeworks Inc. (the “Company”), entered into a sale agreement (the “Sale Agreement”) with Zymeworks Royalty Limited Partnership (the “Subsidiary”), a special purpose entity newly formed by Zymeworks BC and by its general partner Zymeworks General …Material agreement entered · Form 8-K
- Jan 12, 2026Director Appointment On January 9, 2026, the board of directors (the “Board”) of the Company, upon recommendation from the nominating and corporate governance committee of the Board appointed Mr. Brian Cherry as a Class II director of the Company effective January 12, 2026, with a term expiring at the Company’s 2026 …Earnings release · Form 8-K
- Nov 18, 2025On November 16, 2025, Mr. Scott Platshon submitted his resignation from the board of directors (the “Board”) of Zymeworks Inc. (the “Company”), effective immediately.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…